QVA149 versus glycopyrronium for COPD
- PMID: 24429209
- DOI: 10.1016/S2213-2600(13)70115-2
QVA149 versus glycopyrronium for COPD
Comment in
-
QVA149 versus glycopyrronium for COPD - authors' reply.Lancet Respir Med. 2013 Jul;1(5):e23. doi: 10.1016/S2213-2600(13)70104-8. Epub 2013 Jul 8. Lancet Respir Med. 2013. PMID: 24429211 No abstract available.
Comment on
-
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.Lancet Respir Med. 2013 May;1(3):199-209. doi: 10.1016/S2213-2600(13)70052-3. Epub 2013 Apr 23. Lancet Respir Med. 2013. PMID: 24429126 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical